Free tool
FAERS Monitor: Ebanga
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761172 or its brand name (Ebanga, Ansuvimab-Zykl). Reports on generic versions are filed under their own applications.
Reports
3
Serious
3
100% of reports
Hospitalization
2
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective for unapproved indication1
- ebola disease1
- foetal exposure during pregnancy1
- low birth weight baby1
- maternal exposure during pregnancy1
- off label use1
- postpartum haemorrhage1
- premature baby1
- premature delivery1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,156 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| ebola disease | 1 | 438628.2 | 82268.1 | 103,206 |
| postpartum haemorrhage | 1 | 5210.1 | 1050.6 | 1,301 |
| low birth weight baby | 1 | 882.4 | 178.1 | 220 |
| premature delivery | 1 | 440.3 | 88.9 | 109 |
| premature baby | 1 | 233.0 | 47.0 | 57 |
| drug ineffective for unapproved indication | 1 | 127.8 | 25.8 | 31 |
| foetal exposure during pregnancy | 1 | 86.3 | 17.4 | 21 |
| maternal exposure during pregnancy | 1 | 78.7 | 15.9 | 19 |
| off label use | 1 | 8.0 | 1.6 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.